ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01319331
Recruitment Status : Completed
First Posted : March 21, 2011
Last Update Posted : March 24, 2017
Sponsor:
Collaborator:
Omni Bio Pharmaceutical, Inc.
Information provided by (Responsible Party):
University of Colorado, Denver

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2015
  Actual Study Completion Date : May 2016